Screening and surveillance for gastric cancer in the United States: Is it needed?
暂无分享,去创建一个
Joo Ha Hwang | Gwang Ha Kim | G. Kim | J. Hwang | Sung-Jo Bang | Peter S Liang | Sung Jo Bang | Peter S. Liang | Sung‐Jo Bang
[1] Inaba Shizuyo,et al. Evaluation of a screening program on reduction of gastric cancer mortality in Japan: preliminary results from a cohort study. , 1999 .
[2] H. El‐Serag,et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA , 2002, Gut.
[3] A. Oshima,et al. Fundal atrophic gastritis as a risk factor for gastric cancer , 1993, International journal of cancer.
[4] Y. Sugisaki,et al. Helicobacter pylori infection‐negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics , 2007, Cancer science.
[5] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[6] J. Guarner,et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. , 2003, Human pathology.
[7] P. Malfertheiner,et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2012, Endoscopy.
[8] C. Lopes,et al. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. , 2004, Neoplasia.
[9] M. Rugge,et al. Gastric dysplasia: the Padova international classification. , 2000, The American journal of surgical pathology.
[10] J. Paul,et al. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females , 2008, Gut.
[11] Manami Inoue,et al. Gastric cancer screening and subsequent risk of gastric cancer: A large‐scale population‐based cohort study, with a 13‐year follow‐up in Japan , 2006, International journal of cancer.
[12] J. Gisbert,et al. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence , 2013, International journal of cancer.
[13] S. Kudo,et al. Acetic acid spray enhances accuracy of narrow-band imaging magnifying endoscopy for endoscopic tissue characterization of early gastric cancer. , 2014, Gastrointestinal endoscopy.
[14] E. Kuipers,et al. Narrow Band Imaging for the Detection of Gastric Intestinal Metaplasia and Dysplasia During Surveillance Endoscopy , 2010, Digestive Diseases and Sciences.
[15] S. Hisamichi,et al. Mass screening for gastric cancer by X-ray examination. , 1984, Japanese journal of clinical oncology.
[16] Y. Kodera,et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry , 2011, Gastric Cancer.
[17] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[18] K. Haruma,et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study , 2007, Scandinavian journal of gastroenterology.
[19] Masakazu Hattori,et al. Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registry , 2008, Scandinavian journal of gastroenterology.
[20] D. Park,et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type , 2010, BMC gastroenterology.
[21] A. Sigurdsson,et al. The long term results of endoscopic surveillance of premalignant gastric lesions , 2002, Gut.
[22] A. Yoshizawa,et al. Conventional Narrow-Band Imaging Has Good Correlation with Histopathological Severity of Helicobacter pylori Gastritis , 2011, Digestive Diseases and Sciences.
[23] E. Kuipers,et al. Epidemiology of Premalignant Gastric Lesions: Implications for the Development of Screening and Surveillance Strategies , 2007, Helicobacter.
[24] Angelo Zullo,et al. Follow-up of intestinal metaplasia in the stomach: When, how and why. , 2012, World journal of gastrointestinal oncology.
[25] G. Maskarinec,et al. The effect of migration on cancer incidence among Japanese in Hawaii. , 2004, Ethnicity & disease.
[26] F. Roviello,et al. Familial gastric cancer and germline mutations of E-cadherin. , 2012, Annali italiani di chirurgia.
[27] John A. Evans,et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. , 2015, Gastrointestinal endoscopy.
[28] T. Rokkas,et al. Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis , 2010, European journal of gastroenterology & hepatology.
[29] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[30] L. Aaltonen,et al. Features of gastric cancer in hereditary non‐polyposis colorectal cancer syndrome , 1997, International journal of cancer.
[31] Sheng Ge,et al. Association between Habitual Dietary Salt Intake and Risk of Gastric Cancer: A Systematic Review of Observational Studies , 2012, Gastroenterology research and practice.
[32] Bo Chen,et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. , 2009, European journal of cancer.
[33] M. Kubo,et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. , 2006, American journal of epidemiology.
[34] M. Asaka,et al. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. , 1995, European journal of gastroenterology & hepatology.
[35] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[36] D. Morgan,et al. Sex Hormones, Hormonal Interventions, and Gastric Cancer Risk: A Meta-analysis , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[37] S. Narod,et al. Family history and the risk of gastric cancer , 2009, British Journal of Cancer.
[38] Z. Ge,et al. Application of magnifying endoscopy with narrow-band imaging in diagnosing gastric lesions: a prospective study. , 2012, Gastrointestinal endoscopy.
[39] D. Huntsman,et al. Gastric cancer: New genetic developments , 2005, Journal of surgical oncology.
[40] A. Rastogi,et al. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. , 2011, Gastrointestinal endoscopy.
[41] M. Gail,et al. No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. , 2002, Preventive medicine.
[42] B. Hankey,et al. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. , 2008, Cancer Causes & Control.
[43] Tomotaka Sobue,et al. The Japanese guidelines for gastric cancer screening. , 2008, Japanese journal of clinical oncology.
[44] J. Ford,et al. Genetic Testing by Cancer Site: Stomach , 2012, Cancer journal.
[45] T. Ledin,et al. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. , 1989, Scandinavian journal of gastroenterology.
[46] R. Fry,et al. 17β-Estradiol and Tamoxifen Prevent Gastric Cancer by Modulating Leukocyte Recruitment and Oncogenic Pathways in Helicobacter Pylori–Infected INS-GAS Male Mice , 2011, Cancer Prevention Research.
[47] N. Yoshimura,et al. Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged Males , 2008, Cancer Epidemiology Biomarkers & Prevention.
[48] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[49] K. Sugano,et al. Screening of gastric cancer in Asia. , 2015, Best practice & research. Clinical gastroenterology.
[50] Nayoung Kim,et al. Diagnosis and Management of High Risk Group for Gastric Cancer , 2015, Gut and liver.
[51] J Pohl,et al. Computed virtual chromoendoscopy: a new tool for enhancing tissue surface structures , 2007, Endoscopy.
[52] J. Fraumeni,et al. Family history and risk of stomach cancer in Italy. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[53] H. Gouveia,et al. External validation of a classification for methylene blue magnification chromoendoscopy in premalignant gastric lesions. , 2008, Gastrointestinal endoscopy.
[54] N. Samadder,et al. Hereditary and Common Familial Colorectal Cancer: Evidence for Colorectal Screening , 2015, Digestive Diseases and Sciences.
[55] Khean Lee Goh,et al. Screening for gastric cancer in Asia: current evidence and practice. , 2008, The Lancet. Oncology.
[56] Andrew Y. Wang,et al. Gastric intestinal metaplasia and early gastric cancer in the west: a changing paradigm. , 2014, Gastroenterology & hepatology.
[57] A. Helicobacter,et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.
[58] Nayoung Kim,et al. Stomach Cancer Risk in Gastric Cancer Relatives: Interaction Between Helicobacter pylori Infection and Family History of Gastric Cancer for the Risk of Stomach Cancer , 2010, Journal of clinical gastroenterology.
[59] X. Zuo,et al. Magnified and enhanced computed virtual chromoendoscopy in gastric neoplasia: a feasibility study. , 2013, World journal of gastroenterology.
[60] N. Lunet,et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case–control and meta-analysis , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[61] R. Busuttil,et al. Intestinal metaplasia: A premalignant lesion involved in gastric carcinogenesis , 2009, Journal of gastroenterology and hepatology.
[62] A. Tashiro,et al. Comparing mass screening techniques for gastric cancer in Japan. , 2006, World journal of gastroenterology.
[63] K. Sugano,et al. Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition , 2010, Helicobacter.
[64] H. Yatsuya,et al. Prospective study of screening for stomach cancer in Japan , 2003, International journal of cancer.
[65] C. la Vecchia,et al. Family history and the risk of stomach and colorectal cancer , 1992, Cancer.
[66] Takanori Yoshida,et al. Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival , 2001, Gastric Cancer.
[67] R. Wong,et al. Ethnic Disparities in Gastric Cancer Incidence and Survival in the USA: An Updated Analysis of 1992–2009 SEER Data , 2014, Digestive Diseases and Sciences.
[68] L. Brown,et al. Epidemiologic trends in esophageal and gastric cancer in the United States. , 2002, Surgical oncology clinics of North America.
[69] Y. Yamaji,et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study , 2005, Gut.
[70] I. Choi. [Gastric cancer screening and diagnosis]. , 2009, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[71] N. Lunet,et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies , 2008, Cancer Causes & Control.
[72] Jaw-Town Lin. Screening of gastric cancer: who, when, and how. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[73] M. Kaise. Advanced endoscopic imaging for early gastric cancer. , 2015, Best practice & research. Clinical gastroenterology.
[74] Samloff Im. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. , 1971 .
[75] T. Yoshikawa,et al. Is gastric carcinoma different between Japan and the United States? , 2000, Cancer.
[76] W. Liebman,et al. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. , 1973, Gastroenterology.
[77] Sharmila Anandasabapathy,et al. Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[78] J. Guarner,et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[79] E. Bollschweiler,et al. Is the prognosis for Japanese and German patients with gastric cancer really different? , 1993, Cancer.
[80] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[81] C. la Vecchia,et al. A meta-analysis on alcohol drinking and gastric cancer risk. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[82] K. Choi,et al. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[83] I. Choi,et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees , 2009, European journal of gastroenterology & hepatology.
[84] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[85] Jae Seong Jang,et al. Differences in the Survival of Gastric Cancer Patients after Gastrectomy according to the Medical Insurance Status , 2013, Journal of gastric cancer.
[86] M. Ghigna,et al. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. , 2006, Human pathology.
[87] M. Piazuelo,et al. Pathology of Gastric Intestinal Metaplasia: Clinical Implications , 2010, The American Journal of Gastroenterology.
[88] M. Asaka,et al. Recent development of gastric cancer prevention. , 2012, Japanese journal of clinical oncology.
[89] C. Hamashima,et al. A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan , 2013, PloS one.
[90] E. Kuipers,et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. , 2008, Gastroenterology.
[91] R. Pounder,et al. The prevalence of Helicobacter pylori infection in different countries. , 1995, Alimentary pharmacology & therapeutics.
[92] M. Gail,et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. , 2006, Journal of the National Cancer Institute.
[93] I. Tsuji,et al. The evaluation of screening for gastric cancer in miyagi prefecture, Japan: A population‐based case‐control study , 1995, International journal of cancer.
[94] K. Choi,et al. Screening for Gastric Cancer in Korea: Population-Based Preferences for Endoscopy versus Upper Gastrointestinal Series , 2009, Cancer Epidemiology Biomarkers & Prevention.
[95] M. Dinis-Ribeiro,et al. Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost‐Effectiveness Studies , 2013, Helicobacter.